TG Therapeutics TGTX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's inventories?
- TG Therapeutics (TGTX) reported inventories of $26.35M in Q1 2026.
- How has TG Therapeutics's inventories changed year-over-year?
- TG Therapeutics's inventories decreased by 83.3% year-over-year, from $157.76M to $26.35M.
- What does inventories mean?
- The value of all products and materials the company currently has on hand to sell or use.
- How do you interpret inventories?
- Rising inventory levels may signal anticipated sales growth or potential overproduction and obsolescence risks.
- How does inventories compare across companies?
- Highly dependent on the commercial stage and the specific nature of the company's product supply chain.